A data mining based clinical decision support system for survival in lung cancer
Beatriz Pontes1, Francisco Núñez2, Cristina Rubio1
1Department of Computer Language and Systems, Universidad de Sevilla, Seville, Spain.
Summary
A new clinical decision support system (CDSS) improves lung cancer survival prediction compared to standard guidelines. This tool aids physicians in evidence-based management and personalized patient discussions.
Area of Science:
- Oncology
- Clinical Decision Support Systems
- Biostatistics
Background:
- Lung cancer patient outcomes are crucial for treatment planning.
- Existing clinical guidelines offer a framework but may lack personalized predictive power.
- Routine clinical data holds potential for enhanced prognostic accuracy.
Purpose of the Study:
- To develop and validate a clinical decision support system (CDSS) for predicting overall survival in lung cancer patients.
- To compare the predictive performance of the CDSS against established clinical guidelines.
- To assess the CDSS's utility in complementing guideline-based care.
Main Methods:
- Prospective, multicenter data from 543 lung cancer patients (2013-2017) with 1167 variables were utilized.
- Development of the CDSS employed Data Mining techniques, including XGBoost and Generalized Linear Models algorithms.
- Comparative analysis of prediction accuracy between the CDSS and clinical guidelines was performed using receiver-operating characteristic curves (AUCs).
Main Results:
- The CDSS demonstrated superior predictive performance for overall survival compared to clinical guidelines, with AUCs generally above 0.70 versus below 0.70 for guidelines.
- Statistically significant improvements in AUCs were observed for the CDSS across most comparisons (p < 0.05).
- The highest AUCs (> 0.90) were achieved for predicting survival in small cell lung cancer patients using the CDSS.
Conclusions:
- The developed CDSS shows significant potential to enhance the prediction of survival in lung cancer patients.
- The CDSS can support physicians in providing evidence-based management recommendations.
- This tool facilitates individualized prognosis discussions, improving patient care.
Related Concept Videos
Cancer Survival Analysis
478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478
Kaplan-Meier Approach
296
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
296
Statistical Methods for Analyzing Epidemiological Data
592
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
592


